Hematology

Houston company signs proteomic tech agreement with MD Anderson

Shares fall 2 percent in wake of setback

New study of breast cancer therapies could be a model for global clinical trials

Surveillance Data Inc. acquires trialytics to deliver improved data-driven clinical trial development services

The Netherlands Toxicogenomics Centre lands $100M to develop better tox data

Dana-Farber, Merck team up to focus on cancer drug development

DNA mutations found in a type of non-Hodgkin lymphoma that has a poor prognosis has led researchers at the National Cancer Institute

A research team led by Fred Hutchinson Cancer Research Center

Oxford Genome Sciences partners with Amgen to leverage its OGAP cancer protein database

Beckman Coulter launches Q-Check quality certification